135 related articles for article (PubMed ID: 11955816)
1. Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium.
Agu RU; Vu Dang H; Jorissen M; Willems T; Kinget R; Verbeke N
Int J Pharm; 2002 Apr; 237(1-2):179-91. PubMed ID: 11955816
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium.
Agu RU; Vu Dang H; Jorissen M; Kinget R; Verbeke N
Peptides; 2004 Apr; 25(4):563-9. PubMed ID: 15165710
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human nasal primary culture systems to investigate peptide metabolism.
Hoang VD; Uchenna AR; Mark J; Renaat K; Norbert V
Int J Pharm; 2002 May; 238(1-2):247-56. PubMed ID: 11996828
[TBL] [Abstract][Full Text] [Related]
4. Aminopeptidase activity in human nasal mucosa.
Ohkubo K; Baraniuk JN; Hohman R; Merida M; Hersh LB; Kaliner MA
J Allergy Clin Immunol; 1998 Nov; 102(5):741-50. PubMed ID: 9819290
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Marttin E; Verhoef JC; Merkus FW
J Drug Target; 1998; 6(1):17-36. PubMed ID: 9769018
[TBL] [Abstract][Full Text] [Related]
6. The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption.
Hussain MA; Shenvi AB; Rowe SM; Shefter E
Pharm Res; 1989 Feb; 6(2):186-9. PubMed ID: 2788271
[TBL] [Abstract][Full Text] [Related]
7. Effects of various protease inhibitors on the stability and permeability of [D-Ala2,D-Leu5]enkephalin in the rat intestine: comparison with leucine enkephalin.
Uchiyama T; Kotani A; Kishida T; Tatsumi H; Okamoto A; Fujita T; Murakami M; Muranishi S; Yamamoto A
J Pharm Sci; 1998 Apr; 87(4):448-52. PubMed ID: 9548897
[TBL] [Abstract][Full Text] [Related]
8. Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors.
Hussain MA; Koval CA; Shenvi AB; Aungst BJ
J Pharm Sci; 1990 May; 79(5):398-400. PubMed ID: 2352157
[TBL] [Abstract][Full Text] [Related]
9. Drug metabolism in the nasal mucosa.
Sarkar MA
Pharm Res; 1992 Jan; 9(1):1-9. PubMed ID: 1589391
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of nasal absorption of drugs. III: Nasal absorption of leucine enkephalin.
Faraj JA; Hussain AA; Aramaki Y; Iseki K; Kagoshima M; Dittert LW
J Pharm Sci; 1990 Aug; 79(8):698-702. PubMed ID: 2231332
[TBL] [Abstract][Full Text] [Related]
11. Hydrolysis of leucine enkephalin in the nasal cavity of the rat--a possible factor in the low bioavailability of nasally administered peptides.
Hussain A; Faraj J; Aramaki Y; Truelove JE
Biochem Biophys Res Commun; 1985 Dec; 133(3):923-8. PubMed ID: 4084310
[TBL] [Abstract][Full Text] [Related]
12. Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity.
Marttin E; Verhoef JC; Romeijn SG; Merkus FW
Pharm Res; 1995 Aug; 12(8):1151-7. PubMed ID: 7494827
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.
Shao Z; Krishnamoorthy R; Mitra AK
Pharm Res; 1992 Sep; 9(9):1157-63. PubMed ID: 1409397
[TBL] [Abstract][Full Text] [Related]
14. [Promoting mechanism of enhancers and transport pathway of large hydrophilic molecular across nasal epithelium studied by ESR and CLSM technologies].
Zhang YJ; Zhang Q; Yang J; Sun MJ; Wang XL; Chen MX; Wang Q; Jiang H
Yao Xue Xue Bao; 2007 Nov; 42(11):1195-200. PubMed ID: 18300478
[TBL] [Abstract][Full Text] [Related]
15. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW
Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535
[TBL] [Abstract][Full Text] [Related]
16. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts.
Tengamnuay P; Sahamethapat A; Sailasuta A; Mitra AK
Int J Pharm; 2000 Mar; 197(1-2):53-67. PubMed ID: 10704793
[TBL] [Abstract][Full Text] [Related]
17. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
18. Transmucosal delivery of leucine enkephalin: stabilization in rabbit enzyme extracts and enhancement of permeation through mucosae.
Sayani AP; Chun IK; Chien YW
J Pharm Sci; 1993 Nov; 82(11):1179-85. PubMed ID: 8289138
[TBL] [Abstract][Full Text] [Related]
19. The influence of absorption enhancers on nasal absorption of acyclovir.
Chavanpatil MD; Vavia PR
Eur J Pharm Biopharm; 2004 May; 57(3):483-7. PubMed ID: 15093597
[TBL] [Abstract][Full Text] [Related]
20. Transport kinetics of leucine enkephalin across Caco-2 monolayers: quantitative analysis for contribution of enzymatic and transport barrier.
Quan YS; Fujita T; Tohara D; Tsuji M; Kohyama M; Yamamoto A
Life Sci; 1999; 64(14):1243-52. PubMed ID: 10210267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
